Figure 3.

A low thymic function is associated with a higher relapse risk. Mean (±SE) number of log10 sjTREC/ Blood μL (A) and betaTREC/ Blood μL (B), before, 3 and 6 months after transplantation in patients with hematological malignancies that received either a T-cell depleted haploidentical Hematopoietic Stem Cell Transplantation or an Unrelated Donor Cord Blood Transplantation (Mal.) or the former type of allograft only (Haplo). Patients who experienced relapse were represented with gray dotted lines, while patients maintaining complete remission with black plain lines. ^*p < 0.05, ^**p < 0.01. Cumulative incidence of relapse in patients affected by malignant disorders who did or did not have detectable betaTREC before (C), and at month 6 after graft (D) (p in Log Rank test).